Search Results - "Henry, Jake Y."
-
1
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
Published in Nature communications (08-02-2023)“…Emerging variants of concern (VOCs) are threatening to limit the effectiveness of SARS-CoV-2 monoclonal antibodies and vaccines currently used in clinical…”
Get full text
Journal Article -
2
Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
Published in mAbs (01-01-2021)“…Antibodies against coronavirus spike protein potently protect against infection and disease, but whether such protection can be extended to variant…”
Get full text
Journal Article -
3
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma
Published in The Journal of experimental medicine (26-08-2013)“…Treatment with monoclonal antibody specific for cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), an inhibitory receptor expressed by T lymphocytes, has…”
Get full text
Journal Article -
4
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Published in Science (American Association for the Advancement of Science) (25-03-2016)“…As tumors grow, they acquire mutations, some of which create neoantigens that influence the response of patients to immune checkpoint inhibitors. We explored…”
Get full text
Journal Article -
5
Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4 + PD-1 + Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma
Published in Clinical cancer research (01-07-2020)“…Immune dysregulation is described in multiple myeloma. While preclinical models suggest a role for altered T-cell immunity in disease progression, the…”
Get full text
Journal Article -
6
Enhanced cross‐priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide
Published in Immunology (01-07-2013)“…Summary The IMiDs® immunomodulatory compounds lenalidomide and pomalidomide are agents with anti‐inflammatory, immunomodulatory and anti‐cancer activity. An…”
Get full text
Journal Article -
7
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability
Published in Immunity (Cambridge, Mass.) (14-12-2021)“…Viral mutations are an emerging concern in reducing SARS-CoV-2 vaccination efficacy. Second-generation vaccines will need to elicit neutralizing antibodies…”
Get full text
Journal Article -
8
Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Published in Cancer discovery (01-10-2020)“…Before squamous cell lung cancer develops, precancerous lesions can be found in the airways. From longitudinal monitoring, we know that only half of such…”
Get more information
Journal Article -
9
Human genomic DNA is widely interspersed with i-motif structures
Published in The EMBO journal (29-08-2024)“…DNA i-motif structures are formed in the nuclei of human cells and are believed to provide critical genomic regulation. While the existence, abundance, and…”
Get full text
Journal Article -
10
CD25-T reg -depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity
Published in Nature cancer (01-12-2020)“…Intratumoral regulatory T cell (Treg) abundance associates with diminished anti-tumor immunity and poor prognosis in human cancers. Recent work demonstrates…”
Get full text
Journal Article -
11
CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity
Published in Nature cancer (01-12-2020)“…Intratumoral regulatory T cell (Treg) abundance associates with diminished anti-tumor immunity and poor prognosis in human cancers. Recent work demonstrates…”
Get full text
Journal Article -
12
TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells
Published in Blood (24-12-2015)“…Cytomegalovirus (CMV) infection is responsible for substantial morbidity and mortality after allogeneic hematopoietic stem cell transplant. T-cell immunity is…”
Get full text
Journal Article -
13
CMV promotes recipient T-cell immunity following reduced-intensity T-cell–depleted HSCT, significantly modulating chimerism status
Published in Blood (22-01-2015)“…Cytomegalovirus (CMV) remains a significant cause of morbidity after allogeneic hematopoietic stem cell transplantation (HSCT). Clinical risk varies according…”
Get full text
Journal Article -
14
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
Published in Nature microbiology (01-06-2022)“…Genetically distinct variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged since the start of the COVID-19 pandemic. Over this…”
Get full text
Journal Article -
15
The Heterogeneity of Ly6Chi Monocytes Controls Their Differentiation into iNOS+ Macrophages or Monocyte-Derived Dendritic Cells
Published in Immunity (Cambridge, Mass.) (20-12-2016)“…Inflammation triggers the differentiation of Ly6Chi monocytes into microbicidal macrophages or monocyte-derived dendritic cells (moDCs). Yet, it is unclear…”
Get full text
Journal Article -
16
microarray study of altered gene expression in colorectal cancer cells after treatment with immunomodulatory drugs: differences in action in vivo and in vitro
Published in Molecular biology reports (01-04-2010)“…Thalidomide and lenalidomide are FDA approved for the treatment of multiple myeloma, and along with pomalidomide are being investigated in a variety of other…”
Get full text
Journal Article -
17
The T cell differentiation landscape is shaped by tumour mutations in lung cancer
Published in Nature cancer (01-05-2020)“…Tumour mutational burden (TMB) predicts immunotherapy outcome in non-small cell lung cancer (NSCLC), consistent with immune recognition of tumour neoantigens…”
Get full text
Journal Article -
18
Abstract 3812: A best in class anti-CD38 antibody with antitumor and immune-modulatory properties
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Targeting CD38 in multiple myeloma has resulted in outstanding responses. CD38 is widely expressed on myeloma cells and other hematological…”
Get full text
Journal Article -
19
Association of the imbalance between early and late differentiated intra-tumor CD4 T cells with mutational burden in non-small cell lung cancer
Published in Journal of clinical oncology (20-05-2019)“…Abstract only 2590 Background: CD4 T helper cells are key orchestrators of immunity in states of persistent antigen exposure. In chronic viral infection, loss…”
Get full text
Journal Article -
20
The Heterogeneity of Ly6Chi Monocytes Controls Their Differentiation into iNOS+ Macrophages or Monocyte-Derived Dendritic Cells
Published in Immunity (Cambridge, Mass.) (20-12-2016)“…Inflammation triggers the differentiation of Ly6C(hi) monocytes into microbicidal macrophages or monocyte-derived dendritic cells (moDCs). Yet, it is unclear…”
Get full text
Journal Article